Publications

APCARI > Blog > Publications > CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update

Publications

CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update

By:
Contributors: Nawaid Usmani, MD, FRCPC, Scott North, MD, FRCPC, MHPE

Can Urol Assoc J. 2013 Jul-Aug;7(7-8):231-7. doi: 10.5489/cuaj.1542.

Saad F1, Hotte S, Catton C, Drachenberg D, Finelli A, Fleshner N, Gleave M, Kapoor A, Kassouf W, Loblaw A, North S, Usmani N, Chi KN.

cuaj-7-8-231f1

PubMed

Download PDF

Stay Informed

To stay up to date on all the latest news and publications, subscribe to our newsletter!

Recent Publications

Cohort profile: APCaRI Registry and Biorepository facilitates technology translation to the clinic through the use of linked, longitudinal clinical and patient-reported data and biospecimens from men in Alberta, Canada Posted on Nov 17 20 at 1:48pm
Small cell-like glandular proliferation of prostate: A rare lesion not related to small cell prostate cancer Posted on Apr 20 17 at 4:22pm
Malakoplakia associated with prostatic adenocarcinoma: Report of 4 cases and literature review Posted on Apr 20 17 at 4:18pm

APCaRI Registry and Biorepository enrolls 1500th participant – 30% of our goal

We are pleased to announce that the Alberta Prostate Cancer Registry and Biorepository reached 30% of its accrual goal by enrolling participant 1,500! To date more than 100,000 biosamples are stored in the Canadian Research Biorepository along with comprehensive clinical data – all available for cutting edge research.

This was possible thanks to our wonderful team of clinical research personnel, clinicians and partners who have been working collaboratively to reach our goals!

If you are interested in accessing biospecimens or clinical information, let us know at catalina.vasquez@ualberta.ca

Samples available from participants with prostate cancer and age-matched men with negative biopsy
  • Serum (400uL/vial)
  • Plasma (400uL/vial)
  • Buffy Coat (~300uL/vial)
  • Red Blood Cells (400uL/vial)
  • Urine (400uL/vial)
  • Semen (~400uL/vial)
Clinical Information available
  • Demographic information and co-morbidities
  • Family history of prostate cancer
  • Pathology and diagnosis details
  • Clinical and pathological staging
  • Treatment history
  • Outcomes
  • Biospecimen collection, sample availability and processing details
- Unknown